Elisabetta Trabetti-rekin lankidetzan egindako argitalpenak (8)

2011

  1. Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

    Journal of the American College of Cardiology, Vol. 58, Núm. 1, pp. 30-39

2006

  1. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 26, Núm. 8, pp. 1895-1900

  2. Influence of the CD14 C260T Promoter Polymorphism on C-Reactive Protein Levels in Patients With Coronary Artery Disease

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1182-1184

  3. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

    Platelets, Vol. 17, Núm. 8, pp. 586-590

2005

  1. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

    Thrombosis Research, Vol. 116, Núm. 6, pp. 491-497

  2. Variability in platelet aggregation following sustained Aspirin and Clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene

    American Journal of Cardiology, Vol. 96, Núm. 8, pp. 1095-1099

2004

  1. 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment

    Blood Coagulation and Fibrinolysis, Vol. 15, Núm. 5, pp. 427-433

  2. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

    Blood Coagulation and Fibrinolysis, Vol. 15, Núm. 1, pp. 89-93